Results 11 to 20 of about 9,092,985 (264)

Recent Progress in Lyme Disease and Remaining Challenges

open access: yesFrontiers in Medicine, 2021
Lyme disease (also known as Lyme borreliosis) is the most common vector-borne disease in the United States with an estimated 476,000 cases per year. While historically, the long-term impact of Lyme disease on patients has been controversial, mounting ...
Jason R. Bobe   +30 more
semanticscholar   +1 more source

Use of Commercial Claims Data for Evaluating Trends in Lyme Disease Diagnoses, United States, 2010–2018

open access: yesEmerging Infectious Diseases, 2021
We evaluated MarketScan, a large commercial insurance claims database, for its potential use as a stable and consistent source of information on Lyme disease diagnoses in the United States.
Amy M Schwartz   +4 more
semanticscholar   +1 more source

Effect of Borrelia burgdorferi on the Expression of miRNAs in Breast Cancer and Normal Mammary Epithelial Cells

open access: yesMicroorganisms, 2023
Breast cancer is one of the leading causes of death in women worldwide. Recent studies have demonstrated that inflammation due to infections with microorganisms could play a role in breast cancer development.
Ananya Debbarma   +4 more
doaj   +1 more source

Effect of Invasion of Borrelia burgdorferi in Normal and Neoplastic Mammary Epithelial Cells

open access: yesAntibiotics, 2021
Borrelia burgdorferi, the causative agent of Lyme Disease, is known to be able to disseminate and colonize various organs and tissues of its hosts, which is very crucial for its pathogenicity and survival.
Gauri Gaur   +6 more
doaj   +1 more source

Why Lyme disease is common in the northern US, but rare in the south: The roles of host choice, host-seeking behavior, and tick density

open access: yesPLoS Biology, 2021
Lyme disease is common in the northeastern United States, but rare in the southeast, even though the tick vector is found in both regions. Infection prevalence of Lyme spirochetes in host-seeking ticks, an important component to the risk of Lyme disease,
H. Ginsberg   +15 more
semanticscholar   +1 more source

Incidence of carditis and predictors of pacemaker implantation in patients hospitalized with Lyme disease.

open access: yesPLoS ONE, 2021
BackgroundLyme carditis, defined as direct infection of cardiac tissue by Borrelia bacteria, affects up to 10% of patients with Lyme disease. The most frequently reported clinical manifestation of Lyme carditis is cardiac conduction system disease.
Uwajachukwumma A Uzomah   +9 more
doaj   +2 more sources

Lyme Disease in the Era of COVID-19: A Delayed Diagnosis and Risk for Complications

open access: yesCase Reports in Infectious Diseases, 2021
We describe a patient with fever and myalgia who did not have COVID-19 but instead had Lyme disease. We propose that the co-occurrence of COVID-19 and Lyme disease during the spring of 2020 resulted in a delayed diagnosis of Lyme disease due to COVID-19 ...
Cheryl B. Novak   +2 more
doaj   +1 more source

The Platelet Fraction Is a Novel Reservoir to Detect Lyme Borrelia in Blood

open access: yesBiology, 2020
Serological diagnosis of Lyme disease suffers from considerable limitations. Yet, the technique cannot currently be replaced by direct detection methods, such as bacterial culture or molecular analysis, due to their inadequate sensitivity.
Victoria P. Sanderson   +4 more
doaj   +1 more source

Lyme Disease [PDF]

open access: yesClinical Infectious Diseases, 2000
Lyme disease, which is caused by Borrelia burgdorferi and transmitted in the United States primarily by Ixodes scapularis (the deer tick), is the most common vector borne disease in the United States. Its most frequent manifestation, a characteristic, expanding annular rash (erythema migrans), sometimes accompanied by myalgia, arthralgia, and malaise ...
E D, Shapiro, M A, Gerber
openaire   +2 more sources

Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease.

open access: yesClinical Infectious Diseases, 2020
This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN)
Paul M. Lantos   +32 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy